UGT1A1	drug_target	
SLC7A11	drug_target	
SLCO2B1	drug_target	
HSD11B1	drug_target	
Rocuronium	drug	
Zidovudine	drug	
CHRM3	drug_target	
HTR3A	drug_target	
CYP3A5	drug_target	
SCN10A	drug_target	
HTR2A	drug_target	
HTR1B	drug_target	
PDGFRA	drug_target	
CHRNA2	drug_target	
Prilocaine	drug	
ADRA1A	drug_target	
HCAR2	drug_target	
Rosuvastatin	drug	
HMGCR	drug_target	
ABCB1	drug_target	
CHRM5	drug_target	
CA2	drug_target	
CA1	drug_target	
SLC22A2	drug_target	
Fluoxetine	drug	
CSF1R	drug_target	
RXRG	drug_target	
ADRA2A	drug_target	
CYP17A1	drug_target	
QPRT	drug_target	
SLC5A8	drug_target	
ADRA2C	drug_target	
HTR2C	drug_target	
GSTP1	drug_target	
RARA	drug_target	
Ziprasidone	drug	
HCAR3	drug_target	
ABL1	drug_target	
SLC22A6	drug_target	
CA12	drug_target	
Imatinib	drug	
CYP26A1	drug_target	
SLC6A2	drug_target	
ABCC5	drug_target	
ABCB11	drug_target	
ABCG2	drug_target	
HTR6	drug_target	
CYP2C18	drug_target	
CA4	drug_target	
ABCC1	drug_target	
Phenytoin	drug	
HTR1E	drug_target	
RXRB	drug_target	
SLC16A3	drug_target	
Niacin	drug	
SULT2A1	drug_target	
CYP3A4	drug_target	
ADRA1B	drug_target	
CYP2C9	drug_target	
SLCO1C1	drug_target	
CYP1A1	drug_target	
CYP2C8	drug_target	
ABCC4	drug_target	
DDR1	drug_target	
CYP1B1	drug_target	
ABCA3	drug_target	
CYP2D6	drug_target	
CHRM4	drug_target	
RARB	drug_target	
NR3C1	drug_target	
DRD1	drug_target	
CYP2B6	drug_target	
Inclusion Body Myopathy, Sporadic	phenotype	
SLC16A1	drug_target	
CHRM1	drug_target	
SLCO1B3	drug_target	
Clomipramine	drug	
DRD4	drug_target	
DRD2	drug_target	
NNMT	drug_target	
Fosphenytoin	drug	
RARG	drug_target	
SLC22A11	drug_target	
HRH1	drug_target	
CYP11A1	drug_target	
NTRK1	drug_target	
HTR1A	drug_target	
PTGS1	drug_target	
SLC6A4	drug_target	
PDGFRB	drug_target	
SLC22A1	drug_target	
RXRA	drug_target	
EGFR	drug_target	
SLC22A8	drug_target	
ORM1	drug_target	
SLCO1B1	drug_target	
Myofibrillar myopathy, BAG3-related	phenotype	
Peripheral neuropathy, myopathy, hoarseness, and hearing loss	phenotype	
Prednisone	drug	
DRD3	drug_target	
SLC12A3	drug_target	
Myopathy, scapulohumeroperoneal	phenotype	
Abiraterone	drug	
TK1	drug_target	
ALB	drug_target	
CHRM2	drug_target	
HTR1D	drug_target	
HTR2B	drug_target	
SLC29A2	drug_target	
Acitretin	drug	
HTR7	drug_target	
KIT	drug_target	
CYP1A2	drug_target	
TERT	drug_target	
SLC28A1	drug_target	
RBP1	drug_target	
Hydrochlorothiazide	drug	
CA9	drug_target	
NR1I2	drug_target	
UGT2B7	drug_target	
Saquinavir	drug	
ADRA2B	drug_target	
ABCC2	drug_target	
Erlotinib	drug	
SLCO1A2	drug_target	
SCN5A	drug_target	
CYP2C19	drug_target	
KCNMA1	drug_target	
CYP2A6	drug_target	
SLC22A5	drug_target	
SCN1A	drug_target	
DRD5	drug_target	
Lidocaine	drug	
